NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: City of Hope Medical Center
Conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage I, Colorectal Cancer Stage IV
Interventions: ENCODE
Countries: United States, Italy, Japan, Spain
Colorectal cancer (CRC) once predominantly affected older individuals, but in recent years has witnessed a progressive increase in incidence among young adults. Once rare, early-onset colorectal cancer (EOCRC, that is, a CRC diagnosed before the age of 50) now constitutes 10-15% of all newly diagnosed CRC cases and it stands as the first cause of cancer-related death in young men and the second for young women. This study aims to detect EOCRC with a non-invasive test, using a blood-based molecular assay based on microRNA (ribonucleic acid)
Sex: ALL
Age: 18 Years to 50 Years
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Inclusion Criteria: * Stage I, II, III, IV colorectal cancer (TNM classification, 8th edition) diagnosed before the age of 50 (EOCRC cases) * Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment * Colonoscopy-proven cancer-free status at the time of study inclusion (Non-disease controls) Exclusion Criteria: * Hereditary colorectal cancer syndromes (identified through genetic testing) * Inflammatory bowel diseases * Lack of written informed consent
- Duarte, California, United States
- Milan, Italy
- Kawasaki, Japan
- Mie, Japan
- Tokyo, Japan
- Tokyo, Japan
- Yamagata, Japan
- Barcelona, Spain
- Barcelona, Spain
- Barcelona, Spain
- Madrid, Spain
- Salamanca, Spain
- San Cristóbal de La Laguna, Spain